Skip to main content

Table 2 Categories of PCIs according to PCNE V5.01 classification

From: Pharmaceutical care issues identified by pharmacists in patients with diabetes, hypertension or hyperlipidaemia in primary care settings

No.

Primary domain

Code

Sub-classes

Frequency (%)

1

Adverse drug reactions

P1.1

Hypoglycaemia

19 (2.7)

Gastrointestinal disturbances

19 (2.7)

Cough

13 (1.8)

Muscle ache and cramps

10 (1.4)

Dizziness

5 (0.7)

Others

44 (6.2)

 

Subtotal

  

110 (15.6)

2

Drug choice problems

P2.1

Inappropriate drug

6 (0.8)

P2.3

Inappropriate duplication

5 (0.7)

P2.4

Contraindication

1 (0.1)

P2.5

No clear indication for drug

10 (1.4)

P2.6

No drug prescribed but clear indication

41 (5.8)

P2.7

Inadequate regimen

3 (0.4)

P2.8

Drug not required

1 (0.1)

 

Subtotal

  

67 (9.5)

3

Dosing problem

P3.1

Dose too low or frequency not enough

10 (1.4)

P3.2

Dose too high or frequency too often

10 (1.4)

P3.3

Duration of treatment too short

1 (0.1)

P3.4

Duration of treatment too long

1 (0.1)

P3.5

Inappropriate dosing

2 ((0.3)

 

Subtotal

  

24 (3.4)

4

Drug use problems

P4.1

Drug not taken or administered at all

20 (2.8)

P4.3

Incorrect administration

69 (9.8)

P4.4

Non-adherence to medication

146 (20.7)

 

Subtotal

  

235 (33.3)

5

Drug interaction

P5.1

Potential interaction

4 (0.5)

6

Others

P6.2

Insufficient awareness/knowledge

144 (20.1)

P6.3

Unclear complaints

82 (11.6)

P6.4

Therapy failure

98 (13.9)

P6.5

Worries about complications/ADRs

15 (2.1)

P6.6

Dispensing issues

11 (1.6)

P6.7

Lifestyle modifications

8 (1.1)

P6.8

Monitoring for side effects

3 (0.4)

P6.9

Technical issues

2 (0.3)

 

TOTAL

706 (100)

  1. *Subclasses added, not in The PCNE Classification V 5.01.